Who
Remy Luthringer
CEO
Company insider
Files Form 4 as: CEO, Minerva Neurosciences.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $536K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 Jun 2014
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,690,700 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,690,700 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,250,000 at $0.00 | filing |
| 5 Dec 2024filed 6 Dec 2024 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —105,000 at $0.00 | filing |
| 4 Oct 2023filed 5 Oct 2023 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,450 at $0.00 | filing |
| 2 May 2023filed 2 May 2023 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $14K3,641 at $3.76 | filing |
| 1 May 2023filed 2 May 2023 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $91K23,753 at $3.85 | filing |
| 28 Apr 2023filed 2 May 2023 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Code A | —88,077 at $0.00 | filing |
| 13 Dec 2022filed 14 Dec 2022 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —505,000 at $0.00 | filing |
| 16 Dec 2020filed 16 Dec 2020 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $3,4321,300 at $2.64 | filing |
| 14 Dec 2020filed 16 Dec 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,750 at $0.00 | filing |
| 14 Dec 2020filed 16 Dec 2020 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Code M | —18,750 | filing |
| 13 Oct 2020filed 14 Oct 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 19 Jun 2020filed 17 Aug 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —354,302 at $0.00 | filing |
| 31 Dec 2019filed 3 Jan 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,698 at $0.00 | filing |
| 17 Dec 2019filed 17 Dec 2019 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $17K2,412 at $7.10 | filing |
| 14 Dec 2019filed 17 Dec 2019 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,750 at $0.00 | filing |
| 14 Dec 2019filed 17 Dec 2019 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Code M | —18,750 | filing |
| 17 Dec 2018filed 18 Dec 2018 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $19K2,604 at $7.46 | filing |
News
No headline names them, or the companies they trade most, lately.